Associate Vice President - Exploratory Medicine and Pharmacology
Eli Lilly and Company
Indianapolis, Indiana
Amita Datta-Mannan is currently an Associate Vice President, Asset Team Leader, Clinical Team Leader and Clinical Pharmacologist in the Department of Exploratory Medicine and Pharmacology at Eli Lilly and Company. She earned her Bachelor of Science at McMaster University and her PhD in Protein And Physical Chemistry from Brown University. Dr. Datta-Mannan has ~20 years of experience as a pharmaceutical scientist leading cross-functional drug discovery and development teams in various program and portfolio leadership roles. She is passionate about enabling the progression of novel therapeutics and medicines to improve the quality of life. Along these lines, Dr. Datta-Mannan has contributed to the R&D of multiple medicinal modalities including monoclonal antibodies (Taltz, Omvoh, Emgality) bispecific antibodies, antibody drug conjugates, small molecules (imlunestrant), peptides (Forteo, Mounjaro) and fusion proteins (Trulicity) for autoimmunity, oncology, diabetes, migraine and musculoskeletal disorders. She has key platform expertise in the areas of first in human trials, biopharmaceutical profiling and mechanisms influencing the disposition, biodistribution and metabolism of biologics. Dr. Datta-Mannan has contributed to multiple patents, published over 50 peer reviewed disclosures, including scientific reviews and whitepaper guidance documents, presented/chaired over 30 invited oral presentations and cross industry/regulatory consortia, and serves on the editorial/review board of several journals.
Disclosure information not submitted.
Keynote: Evolving Decentralized Clinical Research: Lessons from Five Years of Progress
Tuesday, November 11, 2025
1:30 PM - 2:30 PM CT